Literature DB >> 9456106

Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion.

R E Helm1, T K Rosengart, M Gomez, J D Klemperer, W J DeBois, F Velasco, J P Gold, N K Altorki, S Lang, S Thomas, O W Isom, K H Krieger.   

Abstract

BACKGROUND: Despite the recent introduction of a number of technical and pharmacologic blood conservation measures, bleeding and allogeneic transfusion remain persistent problems in open heart surgical procedures. We hypothesized that a comprehensive multimodality blood conservation program applied algorithmically on the basis of bleeding and transfusion risk would provide a maximum, cost-effective, and safe reduction in postoperative bleeding and allogeneic blood transfusion.
METHODS: One hundred consecutive patients undergoing coronary artery bypass grafting were prospectively enrolled in a risk factor-based multimodality blood conservation program (MMD group). To evaluate the relative efficacy and safety of this comprehensive approach, comparison was made with a similar group of 90 patients undergoing coronary artery bypass grafting to whom the multimodality blood conservation program was not applied but in whom an identical set of transfusion guidelines was enforced (control group). To evaluate the cost effectiveness of the multimodality program, comparison was also made between patients in the MMD group and a consecutive series of contemporaneous, diagnostic-related group-matched patients.
RESULTS: One hundred consecutive patients in the MMD group underwent coronary artery bypass grafting without allogeneic transfusion. This compared favorably with the control population in whom a mean of 2.2 +/- 6.7 units of allogeneic blood was transfused per patient (34 patients [38%] received transfusion). In addition, the volume of postoperative blood loss at 12 hours in the control group was almost double that of the MMD group (660 +/- 270 mL versus 370 +/- 180 mL [p < 0.001]). Total costs for the MMD group in each of the three major diagnostic-related groups were equivalent to or significantly less than those in the consecutive series of diagnostic-related group-matched patients.
CONCLUSIONS: Comprehensive risk factor-based application of multiple blood conservation measures in an optimized, integrated, and algorithmic manner can significantly decrease bleeding and need of allogeneic transfusion in coronary artery bypass grafting in a safe and cost-effective manner.

Entities:  

Mesh:

Year:  1998        PMID: 9456106     DOI: 10.1016/s0003-4975(97)01004-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Reducing blood transfusion. BMJ 's cover and headline exaggerated importance of study's findings.

Authors:  Alain Vuylsteke; Caroline Gerrard
Journal:  BMJ       Date:  2002-09-21

2.  Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations.

Authors:  Victor A Ferraris; Suellen P Ferraris; Sibu P Saha
Journal:  Int J Angiol       Date:  2011-03

3.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

4.  A technique for autologous priming of the veno-venous bypass circuit during liver transplantation.

Authors:  Anthony G Shackelford; Ashley B Hodge; Kenneth D Chavin; Prabhakar K Baliga
Journal:  J Extra Corpor Technol       Date:  2011-06

5.  The effect of retrograde autologous priming volume on haemodilution and transfusion requirements during cardiac surgery.

Authors:  Korneel Vandewiele; Thierry Bové; Filip M J J De Somer; Daniël Dujardin; Martin Vanackere; Dirk De Smet; Annelies T Moerman; Stefaan Bouchez; Katrien François
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-12

6.  Risk-adjusted clinical outcomes in patients enrolled in a bloodless program.

Authors:  Steven M Frank; Elizabeth C Wick; Amy E Dezern; Paul M Ness; Jack O Wasey; Andrew C Pippa; Elizabeth Dackiw; Linda M S Resar
Journal:  Transfusion       Date:  2014-06-18       Impact factor: 3.157

Review 7.  Blood transfusion and infection after cardiac surgery.

Authors:  Keith A Horvath; Michael A Acker; Helena Chang; Emilia Bagiella; Peter K Smith; Alexander Iribarne; Irving L Kron; Pamela Lackner; Michael Argenziano; Deborah D Ascheim; Annetine C Gelijns; Robert E Michler; Danielle Van Patten; John D Puskas; Karen O'Sullivan; Dorothy Kliniewski; Neal O Jeffries; Patrick T O'Gara; Alan J Moskowitz; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2013-05-03       Impact factor: 4.330

8.  Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience.

Authors:  Claude D Vaislic; Nicolas Dalibon; Oliver Ponzio; Maguette Ba; Eric Jugan; Franck Lagneau; Philippe Abbas; Yves Olliver; Didier Gaillard; Francois Baget; Michel Sportiche; Antoine Chedid; Georges Chaoul; Philippe Maribas; Christiane Dupuy; Bruno Robine; Nicolas Kasanin; Herve Michon; Jean-Michel Ruat; Michel Habis; Touhami Bouharaoua
Journal:  J Cardiothorac Surg       Date:  2012-09-27       Impact factor: 1.637

9.  Aortic valve replacement and repair of left ventricular pseudoaneurysm in a Jehovah's Witness.

Authors:  Andrea Perrotti; Claude Vaislic; Sidney Chocron
Journal:  Res Cardiovasc Med       Date:  2013-02-24

10.  A systematic review of the effect of red blood cell transfusion on mortality: evidence from large-scale observational studies published between 2006 and 2010.

Authors:  Sally Hopewell; Omar Omar; Chris Hyde; Ly-Mee Yu; Carolyn Doree; Mike F Murphy
Journal:  BMJ Open       Date:  2013-05-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.